{"id":"W2330698367","doi":"10.1016/s1499-2671(09)33170-6","title":"XoMA 052, a potential disease-modifying anti-interleukin-1 beta (IL-1 beta) regulatory antibody, shows reductions in hs-cRP, HbA1c and FPG after subcutaneous injection in a randomized, blinded, placebo-controlled trial in subjects with type 2 diabetes mellitus","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Beta cell; BETA (programming language); Diabetes mellitus; Insulin resistance; Inflammation; Blockade; Placebo; Insulin; Internal medicine; Antibody; Pharmacology; Endocrinology; Immunology; Pathology; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001164644,0.001276923,0.002401436,0.0005098073,0.0003623822,0.0006306499,0.0007853242,0.00157697,0.005971625],"category_scores_gemma":[0.0009001263,0.0005345856,0.001049143,0.0004187685,0.0008750733,0.0006820256,0.0001716894,0.002134609,0.0006386407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003643962,"about_ca_system_score_gemma":0.0005256697,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001221371,"about_ca_topic_score_gemma":0.002566715,"domain_scores_codex":[0.9997099,0.0001490272,0.00002126606,0.00004351277,0.00002468299,0.00005162581],"domain_scores_gemma":[0.9995903,0.0001334137,0.00008125649,0.00001957753,0.00002049406,0.0001549354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9463141,0.008843973,0.0008787639,0.0009338964,0.0009506177,0.00008986656,0.00004689716,0.0001890394,0.01135954,0.0001067003,0.0008539887,0.02943257],"study_design_scores_gemma":[0.8956712,0.09762789,0.003797573,0.00003458063,0.0004964965,0.0000602418,0.00002811664,0.0002556688,0.001526043,0.00005560913,0.0004303982,0.00001617259],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873197,0.007128137,0.0006938944,0.0005782406,0.0004740096,0.000890755,0.0006831951,0.0002463813,0.001985735],"genre_scores_gemma":[0.9880037,0.004757699,0.001070804,0.0009117522,0.0004906625,0.0007785856,0.0007874561,0.0000293864,0.003169991],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005971625,"threshold_uncertainty_score":0.01997715,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004486740746574337,"score_gpt":0.2153797127801672,"score_spread":0.2108929720335928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}